511 results on '"Squire, Iain B."'
Search Results
2. Diagnostic accuracy of screening questionnaires for obstructive sleep apnoea in adults in different clinical cohorts: a systematic review and meta-analysis
3. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
4. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
5. Exercise Intolerance in Heart Failure with Preserved Ejection Fraction
6. Abstract 12865: Is Atrial Fibrillation in HFpEF a Distinct Endotype? Insights From Multiparametric MRI and Circulating Fibroinflammatory Markers
7. Biomarkers in Heart Failure: Clinical Insights
8. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
9. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
10. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review
11. A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies
12. Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management
13. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction
14. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
15. Patient, health service factors and variation in mortality following resuscitated out-of-hospital cardiac arrest in acute coronary syndrome: Analysis of the Myocardial Ischaemia National Audit Project
16. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
17. Aortic valve intervention rates in patients of different ethnicity with severe aortic stenosis in Leicestershire, UK
18. A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies
19. Correction to: does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
20. The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions.
21. Regulatory RNAs in Heart Failure
22. Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction
23. Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction
24. Diagnostic accuracy of screening questionnaires for obstructive sleep apnoea in adults in different clinical cohorts: a systematic review and meta-analysis
25. Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
26. Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial
27. Rationale and design of a randomised trial of intravenous iron in patients with heart failure
28. Overstimulation of the ergoreflex—A possible mechanism to explain symptoms in long COVID
29. Proenkephalin and Prognosis After Acute Myocardial Infarction
30. Biomarkers and prognostication in heart failure with reduced and preserved ejection fraction: similar but different?
31. Sacubitril/valsartan: beyond natriuretic peptides
32. Vitamin D and prognosis in acute myocardial infarction
33. Interleukin-21 – A biomarker of importance in predicting myocardial function following acute infarction?
34. Low Levels of Vascular Endothelial Growth Factor B Predict Left Ventricular Remodeling After Acute Myocardial Infarction
35. Right Side of the Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure
36. Interleukin 33 and ST2 in non–ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP
37. Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction
38. Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis
39. Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose
40. Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure
41. Usefulness of Plasma Tissue Inhibitors of Metalloproteinases as Markers of Prognosis After Acute Myocardial Infarction
42. Prognosis For South Asian And White Patients Newly Admitted To Hospital With Heart Failure In The United Kingdom: Historical Cohort Study
43. Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
44. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis
45. Survival in South Asian and White European patients after acute myocardial infarction
46. Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect?
47. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
48. Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
49. Non‐adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography‐tandem mass spectrometry (results of a prospective multicentre study)
50. Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.